Avobis Bio is a clinical-stage biotechnology company dedicated to development of implantable cell therapies to treat debilitating conditions. The investigational portfolio leverages the combination of mesenchymal stem cells and bioabsorbable materials to create novel curative treatments. Formed as a joint venture between Mayo Clinic and W. L. Gore & Associates, Avobis leverages expertise in clinical care, cell biology, materials science and commercialization of medical products to transform patient lives.

Contact Avobis Bio
Visit Website